Assessment of C-Reactive Protein Diagnostic Test Accuracy for Late-Onset Infection in Newborn Infants

Abstract

Background: The assessment of C-Reactive Protein (CRP) diagnostic test accuracy for late-onset infection in newborn infants has garnered significant attention in recent years, highlighting its potential as a critical biomarker in neonatal care. Literature Review: The foundational study by (Vijay Prabhu, 2011) established CRP as a reliable diagnostic test for neonatal septicemia, emphasizing its rapid response to inflammation and its high specificity (96%) for this condition. This study highlighted the importance of monitoring CRP levels as an indicator of treatment efficacy, with significant reductions observed in patients responding positively to therapy. Building upon this groundwork, (Nabulsi et al., 2012) explored the implications of CRP testing in pediatric patients, noting variability in the sensitivity and specificity of CRP tests. This variability raises concerns about the diagnostic accuracy in late-onset infections, suggesting that while CRP is commonly utilized, its results often do not significantly influence clinical decision-making. The authors advocated for a multimodal approach, integrating CRP testing with other clinical assessments to enhance diagnostic accuracy. In 2005, (V. Mikhaylova et al., 2005) examined CRP kinetics in extremely low birth weight infants, introducing high-sensitivity analytic methods that highlighted the complexities of interpreting CRP levels in the context of non-infectious conditions and varying gestational ages. This research reinforced CRP's diagnostic significance while calling for a nuanced understanding of its application in premature neonates. Most recently, (Valeska Elli Brown et al., 2009) focused specifically on the diagnostic accuracy of CRP for late-onset infections, addressing the limitations of existing studies and advocating for comprehensive evaluations of CRP's performance.  Conclusion: In conclusion, the literature underscores CRP's potential as a valuable biomarker for late-onset infections in newborns, yet highlights significant variability in its diagnostic accuracy and practical application in clinical settings. Future research should aim to refine CRP's use in conjunction with other diagnostic tools to enhance its reliability and effectiveness in neonatal care.